-
-
Call more information
660-596-2224 -
Two leading authorities in migraine management announced favorable results in separate trials targeting calcitonin gene-related peptide with mAb treatments for migraine pain. By Vicki Moore, PhD with Lawrence Robbins, MD Managing migraines may improve given the positive outcomes of two Phase 3 trials of monoclonal antibody migraine-preventive treatments directed against the calcitonin gene-related peptide (CGRP) and […]
Read MoreEdited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD More than 1 in 6 adults who survive revascularization for peripheral arterial disease have an unplanned readmission within 30 days, according to a study in the Annals of Internal Medicine. U.S. researchers used the Nationwide Readmissions Database from 2017 to identify nearly 62,000 patients who underwent […]
Read MoreAnesthesia published on Dec 5, 2017 Authors: S. R. Tasbihgou et al Summary Unintended accidental awareness during general anaesthesia represents failure of successful anaesthesia, and so has been the subject of numerous studies during the past decades. As return to consciousness is both difficult to describe and identify, the reported incidence rates vary widely. Similarly, […]
Read MoreAuthors: Tobias Kammerer, M.D. et al Anesthesiology 1 2018, Vol.128, 67-78. Background: The use of artificial colloids has declined in critical care, whereas they are still used in perioperative medicine. Little is known about the nephrotoxic potential in noncritically ill patients during routine surgery. The objective of this trial was to evaluate the influences of albumin 5% […]
Read MoreAuthors: Christopher Brasher, M.D. et al Anesthesiology 1 2018, Vol.128, 4-5. “Preterm infants have substantial intravenous therapeutic needs over prolonged periods of time.” HOW to best insert and maintain central venous catheters in small infants is a question of interest to all health professionals working in the field. The hospitalized small infant population is growing as […]
Read More